microdosing glp 1 how to GLP-1 Maintenance: A Clear Guide Micro-Dosing THE GLP-1 MICRODOSING PROGRAM

"Semaglutide 2.4 mg once a week in adults with overweight or obesity without diabetes: a randomised, double-blind, placebo-controlled trial." The Lancet, vol

Vrang N, Jelsing J, Simonsen L, Jensen AE, Thorup I, Soeborg H, et al

B.DavisB

Comprehensive Side Effects, Safety Risks, and Medical Contraindications for GLP-1 Therapy All GLP-1 medications, whether FDA-approved branded products or compounded formulations prepared by licensed pharmacies registered with FDA as facilities, carry potential risks requiring careful consideration and ongoing medical monitoring

Ironically, the very condition semaglutide treats is itself a major risk factor for blood clots